Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data

ORIC Oric Pharmaceuticals

3.400
-0.110-3.13%
Close 09/23 16:00 ET
3.4000.0000.00%
Post Mkt Price 09/23 16:00 ET
High
3.442
Open
3.430
Turnover
1.19M
Low
3.260
Pre Close
3.510
Volume
353.70K
Market Cap
134.56M
P/E(TTM)
Loss
52wk High
20.910
Shares
39.58M
P/E(Static)
Loss
52wk Low
2.620
Float Cap
99.28M
Bid/Ask %
81.82%
Historical High
40.810
Shs Float
29.20M
Volume Ratio
1.76
Historical Low
2.620
Dividend TTM
--
Div Yield TTM
--
P/B
0.57
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
1.21%
Amplitude
5.17%
Avg Price
3.355
Lot Size
1
Float Cap
99.28M
Bid/Ask %
81.82%
Historical High
40.810
Shs Float
29.20M
Volume Ratio
1.76
Historical Low
2.620
Dividend TTM
--
P/B
0.57
Dividend LFY
--
Turnover Ratio
1.21%
Amplitude
5.17%
Avg Price
3.355
Lot Size
1
Price Forecast

No Data

News

Comment

Company Overview More
Oric Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in the development of cancer treatments that address mechanisms of therapeutic resistance. It specializes in hormone-dependent cancers, key tumor dependencies, and precision oncology. The company was founded by Charles L. Sawyers, Richard A. Heyman, and Scott Lowe in 2014 and is headquartered in South San Francisco, CA.
CEO: Mr. Jacob M. Chacko, M.B.A.,M.D.
Market: NASDAQ
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...